November 17, 2025
Life Science Magazines About Us Contact Us
Life Science Newswire Service™ (LS)
Submit a Press Release
  • Analytical chemistry
  • Business
  • Biomanufacturing & bioprocessing
  • Biotechnology
  • Diagnostics
  • Drug development
  • More News
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • Press Releases
Reading: Focus on Fintiv: Shift in Patent Office Guidance for Discretionary Denials of Patent Challenges
Share
Font ResizerAa
Life Science Newswire Service™ (LS)Life Science Newswire Service™ (LS)
Search
  • Business
  • Press Releases
  • Life Science Magazines
  • Life Sciences
    • Analytical chemistry
    • Biomanufacturing & bioprocessing
    • Biotechnology
    • Diagnostics
    • Drug development
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • About Us
  • Contact Us
  • Submit a Press Release
LS Newswire Service™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC
Life Science Newswire Service™ (LS) > Blog > Life Sciences > Biotechnology > Focus on Fintiv: Shift in Patent Office Guidance for Discretionary Denials of Patent Challenges
Biotechnology

Focus on Fintiv: Shift in Patent Office Guidance for Discretionary Denials of Patent Challenges

By Newsroom
Last updated: April 5, 2025
1 Min Read
Share


On February 28, 2025, the U.S. Patent and Trademark Office announced that it was rescinding a 2022 memorandum that provided guidance regarding the application of the Apple v. Fintiv decision to the Patent Trial and Appeal Board’s discretion to deny patent challenges with pending parallel district court litigation. The PTO has referred parties back to precedent for guidance including Apple Inc. v. Fintiv, Inc. Rescinding the 2022 memorandum also has the effect of effectively removing the proposed rules related to discretionary denial that were under consideration as recently as last year.

35 U.S.C. § 314(a) provides the…



Source link

Share This Article
Facebook Email Copy Link Print

HOT NEWS

Vancouver’s earthquake-resilient water supply tunnel hits milestone

Environmental Science
October 26, 2025

تطبيق “سهم” يحصل على جائزة أفضل تطبيق تداول في السعودية لعام 2025

تعكس الجائزة التزام شركة سهم كابيتال بالابتكار، والتمكين، ودعم النمو الوطني. الرياض، المملكة العربية السعودية…

November 16, 2025

Therapeutic Electrodes Market Projected to Grow at a CAGR of 6.2% During the Forecast Period 2021-2026

  Therapeutic Electrodes Market (I-BusinessNews.Com, August 04, 2021 ) The Therapeutic Electrodes Market size was…

August 4, 2021

Breast Imaging Market to reach USD 5.4 billion by 2025, at a CAGR of 8.1%

(I-BusinessNews.Com, August 05, 2021 ) The breast imaging market is projected to grow from an…

August 5, 2021

YOU MAY ALSO LIKE

Patent Office Releases Role of AI in Inventorship Determinations |

In February, the PTO released “Inventorship Guidance for AI-assisted Inventions (89 CFR 10043) and noted that the Office will issue…

Biotechnology
April 5, 2025

FDA Proposes Risk-Based and Remote Inspection Strategies in New Report

On May 5, 2021, the U.S. Food and Drug Administration (FDA) issued a much-anticipated report, “Resiliency Roadmap for FDA Inspectional…

Biotechnology
April 5, 2025

Further Shifts in Patent Office Guidance for Discretionary Denials Signal Uphill Battles for Patent Challengers

On the heels of the rescission of the Fintiv guidance memorandum, the U.S. Patent and Trademark Office has again reshaped…

Biotechnology
April 5, 2025

Regents of the U. of Cal. v. Broad Inst. – “Just The Facts, Ma’am.” |

The central theme in this interference decision involving U.S. Pat. No. 8,697,359 is the amount and type of evidence required…

Biotechnology
June 6, 2025
Life Science Newswire Service™ (LS)

Contact Us

  • Whatsapp: +1 832-716-2363
  • Skype: Groupwebmedia
  • Telegram: Groupwebmedia

Share Us

About Us

Life Science Newswire Services (LS)™ aggregates, publishes and distributed news about the Life Science industry. In association with EmailWire, LS provides press release distribution services in the Life Science sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us.

Categories

Analytical chemistry
Business
Biomanufacturing & bioprocessing
Biotechnology
Diagnostics
Drug development
Environmental Science
Food & beverage
Forensic science
Healthcare
Hospitals
Lab tools
Materials science
Microbiology
Nanotechnology
Pharma & Biopharma
Pharmacy
Veterinary
Water Management
Life Science Magazines
Press Releases

Recent News

تطبيق “سهم” يحصل على جائزة أفضل تطبيق تداول في السعودية لعام 2025
November 16, 2025
Sahm App Named “Best Trading App Saudi Arabia 2025”
November 16, 2025
QSP Modeling | Preclinical Radiopharmaceuticals Development
November 16, 2025
How Do We Know Methane (CH4) Is Tetrahedral? – Master Organic Chemistry
November 16, 2025

Life Science Magazines

From Integration to Global Expansion: Empowering the Future…
November 15, 2025
Engineering for equivalency: Building reliable, optimized…
November 15, 2025
Life Sciences | Bridging the Workforce Gap: Leveraging…
November 14, 2025
Ethical AI in Healthcare & Life Sciences
November 13, 2025

LS Newswire Service™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?